Houston, Texas — According to state and local development sources, CommonSpirit Health plans to invest $2,100,000.00 to build out 3,928 square feet of new space in Houston. The company plans to occupy the new space…
First to Market, Mojave Moves Beyond Development and Commercialization to Expansion SUNNYVALE, Calif., Dec. 18, 2024 /PRNewswire/ — Mojave Energy Systems, founded to change the nature of air conditioning, today announced that it has raised $9.5 million in Series A…
$17M Series B Round Led by Aquiline to FuelScripta’s Growth into Health Plan and Medicare Advantage Markets BOSTON, Dec. 18, 2024 /PRNewswire/ — “Consumerism in healthcare” is a popular catch phrase, but when it comes to prescription drugs, Americans are…
Plume aims to bring real world tokenization onchain to build out RWAfi ecosystem NEW YORK, Dec. 18, 2024 /PRNewswire/ — Plume, the first fully integrated modular Layer-1 blockchain focused on Real World Asset Finance (RWAfi), today announced the…
Austin, Texas — According to state and local development sources, City of Austin plans to invest $2,800,000.00 to build out 31,361 square feet of new space in Austin. The company plans to occupy the new…
San Saba, Texas — According to state and local development sources, Capital Farm Credit plans to invest $850,000.00 to build out 3,500 square feet of new space in San Saba. The company plans to occupy…
Pecos, Texas — According to state and local development sources, Texas Department of Public Safety plans to invest $1,800,000.00 to build out 2,200 square feet of new space in Pecos. The company plans to occupy…
New funding to accelerate application development of SandboxAQ’s Large Quantitative Models (LQMs) and AI solutions PALO ALTO, Calif., Dec. 18, 2024 /PRNewswire/ — SandboxAQ today announced a round of more than $300 million from Fred Alger Management, LLC, T. Rowe Price…
LONDON and BOSTON, Dec. 19, 2024 /PRNewswire/ — Ottimo Pharma (“Ottimo”), a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, today announces the completion of a Series A financing round of over $140…
The company engineers novel immunotherapies that empower the immune system to target HERV antigens from the dark genome to treat cancer, metabolic disease, and other aging-related diseases Funds to fuel pipeline of off-the-shelf assets through…